An improved method for measuring angiotensin I converting enzyme activity using a highly sensitive angiotensin II radioimmunoassay
- PMID: 3009165
- DOI: 10.1507/endocrj1954.32.803
An improved method for measuring angiotensin I converting enzyme activity using a highly sensitive angiotensin II radioimmunoassay
Abstract
A highly sensitive assay for angiotensin I converting enzyme has been developed by using angiotensin I as a substrate. Angiotensin II generated in the reaction mixture was measured by a newly developed specific radioimmunoassay. To protect against angiotensin II destruction, bestatin, an inhibitor of renin, was also used to inhibit plasma renin activity. The reaction was stopped by adding EDTA and MK-521, inhibitors of angiotensin I converting enzyme. The specificity of the antiserum used for the angiotensin II radioimmunoassay was very high. The cross reactivity with angiotensin I was less than 0.5% and none of the proteolytic enzyme inhibitors crossreacted in the assay. The inhibitory effect of pepstatin on plasma renin activity was very high (more than 80%) under the standard assay conditions employed. Serum angiotensinase activity was completely inhibited by the addition of bestatin. An excellent correlation was obtained between this new method and the spectrophotometric method using a synthetic substrate, Hip-His-Leu. The generation of as little as 12 pM of Angiotensin II can be detected. Such low concentration have not been measurable with the usual spectrophotometric method. This new method will facilitate clinical and experimental studies on this unique enzyme, since very low levels of activity can be determined by this highly sensitive radioimmunoassay for angiotensin II.
Similar articles
-
Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.Pharmacol Toxicol. 1999 Mar;84(3):110-4. doi: 10.1111/j.1600-0773.1999.tb00884.x. Pharmacol Toxicol. 1999. PMID: 10193670 Clinical Trial.
-
Direct evidence for the presence of a different converting enzyme in the hamster cheek pouch.Circ Res. 1979 Apr;44(4):540-4. doi: 10.1161/01.res.44.4.540. Circ Res. 1979. PMID: 218748
-
Conversion of angiotensin-1 to angiotensin-2 by a latent endothelial cell peptidyl dipeptidase that is not angiotensin-converting enzyme.Biochem Biophys Res Commun. 1986 Jan 29;134(2):770-6. doi: 10.1016/s0006-291x(86)80487-9. Biochem Biophys Res Commun. 1986. PMID: 3511910
-
Drugs inhibiting the renin - angiotensin system.Fed Proc. 1981 Jun;40(8):2275-84. Fed Proc. 1981. PMID: 6263716 Review.
-
Pharmacology of angiotensin converting enzyme inhibitors. A review.Am J Med. 1986 Oct 31;81(4C):13-8. doi: 10.1016/0002-9343(86)90939-3. Am J Med. 1986. PMID: 3022580 Review.
Cited by
-
Effect of exercise training on the renin-angiotensin-aldosterone system in healthy individuals: a systematic review and meta-analysis.Hypertens Res. 2016 Mar;39(3):119-26. doi: 10.1038/hr.2015.100. Epub 2015 Sep 24. Hypertens Res. 2016. PMID: 26399454
MeSH terms
Substances
LinkOut - more resources
Full Text Sources